Chitinase Signature in the Plasticity of Neurodegenerative Diseases
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Cristina Russo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pathology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Chitinases, Multiple Sclerosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was founded by PNRR: "Health Extended ALliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision", PNRR: “Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision”.
Abstract (Originalsprache)
Several reports have pointed out that Chitinases are expressed and secreted by various cell types of central nervous system (CNS), including activated microglia and astrocytes. These cells play a key role in neuroinflammation and in the pathogenesis of many neurodegenerative disorders. Increased levels of Chitinases, in particular Chitotriosidase (CHIT-1) and chitinase-3-like protein 1 (CHI3L1), have been found increased in several neurodegenerative disorders. Although having important biological roles in inflammation, to date, the molecular mechanisms of Chitinase involvement in the pathogenesis of neurodegenerative disorders is not well-elucidated. Several studies showed that some Chitinases could be assumed as markers for diagnosis, prognosis, activity, and severity of a disease and therefore can be helpful in the choice of treatment. However, some studies showed controversial results. This review will discuss the potential of Chitinases in the pathogenesis of some neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis, to understand their role as distinctive biomarkers of neuronal cell activity during neuroinflammatory processes. Knowledge of the role of Chitinases in neuronal cell activation could allow for the development of new methodologies for downregulating neuroinflammation and consequently for diminishing negative neurological disease outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pathology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy.
- Laboratory of Neuro-Biomechanics, Section of Physiology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy.
ORCID-Profile: Cristina Russo, Maria Stella Valle, Antonino Casabona, Lucia Malaguarnera
Förderung
- This research was founded by PNRR: "Health Extended ALliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision"
- PNRR: “Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision”
Zitieren
APA
Russo, C., Valle, M. S., Casabona, A., & Malaguarnera, L. (2023). Chitinase Signature in the Plasticity of Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076301
Vancouver
Russo C, Valle MS, Casabona A, Malaguarnera L. Chitinase Signature in the Plasticity of Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076301
BibTeX
@article{Russo2023,
author = {Russo, Cristina and Valle, Maria Stella and Casabona, Antonino and Malaguarnera, Lucia},
title = {Chitinase Signature in the Plasticity of Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076301}
}
EUVIMED